A new study from the University of Illinois suggests that patients with peritoneal mesothelioma who undergo surgery may not get any benefit from having chemotherapy, too. Mesothelioma patients who have cytoreductive surgery, which is also called debulking surgery, tend to live more than four times as long as those who do not have the surgery. Rinsing the abdominal cavity with a heated solution of cancer-killing … Continue reading Study Finds Chemotherapy Unlikely to Improve Peritoneal Mesothelioma Survival
A study of more than 400 patients and their families shows that people coping with cancers such as malignant mesothelioma do better when their medical caregivers show them kindness. The study was originally published in the Journal of Oncology Practice and identifies six specific types of kindness that can help to ease the pain and challenges of mesothelioma treatment. High Tech Must Be Balanced by … Continue reading Mesothelioma Patients May Benefit From Kindness, Study Reveals
When it comes to accurately assessing the extent of an individual case of malignant pleural mesothelioma, Positron Emission Tomography (PET) may be more effective than Computed Tomography (CT). A combination of the two is even better. That conclusion comes from researchers at the University of Toronto who analyzed the cases of more than 100 mesothelioma patients being considered for multimodality therapy at Princess Margaret Cancer … Continue reading PET Beats CT in Study of Mesothelioma Staging Tools
Researchers at one of the nation’s top cancer institutes are betting on a combination of radiation and immunotherapy in the continued pursuit of better treatments for malignant mesothelioma. Memorial Sloan Kettering in New York is now recruiting relapsed mesothelioma patients into a safety and efficacy study of stereotactic body radiation therapy (SBRT) and the immunotherapy drug avelumab. The new trial is based on the idea … Continue reading New Mesothelioma Treatment Combines Immunotherapy and Targeted Radiation
The idea that proton therapy may be a safer alternative to radiotherapy for the asbestos-linked cancer malignant pleural mesothelioma is coming into question in light of recent research. A newly published study of proton therapy in patients with inoperable non-small cell lung cancer, a cancer with many similarities to mesothelioma, showed no difference between proton-based and standard photon-based radiotherapy in terms of lung toxicity or … Continue reading Proton Therapy for Mesothelioma: A Safer Radiation Treatment?
A new study on treatment disparities among lung cancer patients reflects a trend that has been documented among mesothelioma patients, as well; patients who are black or economically disadvantaged are less likely to get potentially life-saving treatments. Like non-small cell lung cancer, pleural mesothelioma affects the lungs. The standard of care is for patients to have a combination of chemotherapy and radiotherapy. For malignant mesothelioma … Continue reading Pleural Mesothelioma Treatment Disparities Seen in Lung Cancer Patients, Too
A team of Egyptian researchers is calling on mesothelioma doctors and patients to rethink their approach to treating this aggressive, asbestos-linked cancer. Scientists with Ain Shams University in Cairo conducted a review of studies on radical multi-modality approaches to malignant mesothelioma treatment and concluded that, despite what some other studies seem to suggest, this may not always be the best approach. What Are Radical Multi-Modal … Continue reading Radical Multi-Modal Mesothelioma Treatment: Is it Worth It?
Too many patients with malignant pleural mesothelioma are not getting the trimodality treatment protocol that could significantly change their outcomes. That is the finding of a newly-published study conducted at MD Anderson Cancer Center in Houston, Texas. Researchers reviewed the records of more than 20,000 patients in the National Cancer Database with a definitive diagnosis of pleural mesothelioma between 2004 and 2014. They discovered that, … Continue reading Many Pleural Mesothelioma Patients May Be Missing Out on Life-Extending Treatments
Treating malignant pleural mesothelioma patients with high doses of targeted radiotherapy after surgery or biopsy may significantly extend their lives. That’s the message from a multi-center mesothelioma study conducted in Italy and recently published in a French medical journal. Mesothelioma Treatment with Radiotherapy Scientists analyzed the cases of 36 malignant pleural mesothelioma patients diagnosed between 2009 and 2012. Nineteen of the patients were treated with … Continue reading High Dose Radiotherapy Improves Mesothelioma Survival in New Study
Researchers in California and Boston say blocking a process by which cells break down and recycle their components into new cells could make mesothelioma tumors more susceptible to chemotherapy. Although the process, known as autophagy, is a natural part of the lives of cells, it can also be induced by certain drugs. Emerging research suggests that the multi-stage process is not only more complex than … Continue reading Blocking This Cellular Process Could Help Mesothelioma Chemotherapy Work Better